The global erythropoietin (EPO) market is anticipated to grow at a significant CAGR during the forecast period (2024-2031). The major factor that is expected to boost the global erythropoietin market includes rise in prevalence of anemic conditions induced from end stage renal disease treatment, chemotherapy, and antiretroviral treatment (ART). Hence, rise in number of treatment cycles for chemotherapy and rising incidences of end stage renal diseases (dialysis) has increased the demand for EPO drugs. Side effects associated with EPO including arterial hypertension, iron deficiency, and influenza-like syndrome and longer duration of EPO treatment (4-6 weeks) restrain growth of the erythropoietin drugs market. Moreover, rise in trends of commercialization of EPO biosimilars, readily available reimbursements, favorable government regulations, and increase in level of awareness regarding benefits of EPO therapeutics are some factors that are expected to fuel the growth of the erythropoietin drugs market during the forecast period. EPO/hematopoietin is a glycoprotein hormone that triggers production of red blood cells in the bone marrow through erythropoiesis. Erythropoietin drug was developed with the objective to treat anemic conditions caused by end stage renal disease (ESRD) disease treatments and dialysis procedures. Followed by ESRD anemic condition, EPO drugs have gained approvals for chemotherapy-induced anemia.
Get Free Sample link @ https://www.omrglobal.com/request-sample/erythropoietin-market
After post-abbreviated new drug application (ANDA) approvals and high success rate of EPO applications for chemotherapy-induced anemia, biopharmaceutical companies turned their attention to another form of induced anemia, namely ART-induced anemia (among HIV patients). Currently, scientists are planning a randomized clinical trial to systematically investigate effects of treating COVID-19 using erythropoietin. It is a hormone/cytokine produced mainly by kidneys via hypoxia inducible factor-2 as its primary transcription factor and through inhibition of apoptosis of RBC precursors. However, EPO has other beneficial cytoprotective effects including anti-ischemic, regenerative, and anti-apoptotic effects in a variety of tissues including lung, kidney, cardiac muscle, nervous system, retina, pancreas, and endothelial cells. Through a special receptor; EPOR-?cR, it conducts its protective effects following trauma in critically ill patients. Thus, impact of COVID-19 pandemic is expected to remain positive for key players in the global erythropoietin market.
Full report of Erythropoietin Market available @ https://www.omrglobal.com/industry-reports/erythropoietin-market
Market Coverage
- Segment Covered-
o By Drug Class
o By Product Type
o By Application
- Regions covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
Competitive Landscape: Amgen Inc., Johnson & Johnson Services, Inc., and F. Hoffman La-Roche AG, among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Erythropoietin Market Report by Segment
By Drug Class
- Biologics
- Biosimilars
By Product Type
- Epoetin-Alfa
- Epoetin-Beta
- Darbepoetin-Alfa
- Others
By Application
- Hematology
- Cancer
- Kidney Disorder
- Others
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/erythropoietin-market
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
